Kunming Qi
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Hematology 30
- Hematopoietic Stem Cell Transplantation 10
- Multiple Myeloma Research and Treatments 8
- Platelet Disorders and Treatments 7
- Acute Myeloid Leukemia Research 5
- Oncology 23
- CAR-T cell therapy research 16
- Co-authors
- Kailin Xu (52 shared papers)Jianlin Qiao (27 shared papers)Lingyu Zeng (26 shared papers)Hai Cheng (28 shared papers)Jiang Cao (26 shared papers)Junnian Zheng (7 shared papers)Zhenyu Li (11 shared papers)Wei Sang (13 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Leukemia Research (2 papers)Biology of Blood and Marrow Transplantation (2 papers)International Immunopharmacology (2 papers)Hematological Oncology (2 papers)
- Partner nations
- ChinaUnited StatesPanama
In The Last Decade
Kunming Qi
49 papers receiving 661 citations
Peers
Comparison fields: 5 of 71
- Hematology 153
- Oncology 364
- Immunology 198
- Cancer Research 50
- Genetics 92
Countries citing papers authored by Kunming Qi
This map shows the geographic impact of Kunming Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunming Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunming Qi more than expected).
Fields of papers citing papers by Kunming Qi
This network shows the impact of papers produced by Kunming Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunming Qi. The network helps show where Kunming Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Kunming Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 126 | |
| 2 | 2021 | 77 | |
| 3 | 2019 | 66 | |
| 4 | Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells. | 2017 | 30 |
| 5 | 2021 | 26 | |
| 6 | 2020 | 23 | |
| 7 | 2018 | 22 | |
| 8 | 2015 | 21 | |
| 9 | 2015 | 20 | |
| 10 | 2020 | 19 | |
| 11 | 2016 | 19 | |
| 12 | 2016 | 18 | |
| 13 | 2018 | 14 | |
| 14 | 2020 | 13 | |
| 15 | 2014 | 12 | |
| 16 | 2018 | 12 | |
| 17 | 2016 | 12 | |
| 18 | 2015 | 11 | |
| 19 | 2015 | 11 | |
| 20 | 2020 | 10 |
About Kunming Qi
Kunming Qi is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Immunology, having authored 61 papers that have together received 667 indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (8 papers), Platelet Disorders and Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Hematology (153 citations), Oncology (364 citations), Immunology (198 citations), Cancer Research (50 citations) and Genetics (92 citations). Kunming Qi has collaborated with scholars based in China, United States and Panama. Frequent co-authors include Kailin Xu, Jianlin Qiao, Lingyu Zeng, Hai Cheng, Jiang Cao, Junnian Zheng, Zhenyu Li, Wei Sang, Gang Wang and Bin Pan. Their work appears in journals such as Frontiers in Immunology, Leukemia Research, Biology of Blood and Marrow Transplantation, International Immunopharmacology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.